Primary |
Prophylaxis |
57.1% |
Disease Recurrence |
14.3% |
Endocarditis |
14.3% |
Infection |
14.3% |
|
Blepharitis |
25.0% |
Ocular Hyperaemia |
25.0% |
Vestibular Disorder |
25.0% |
Balance Disorder |
12.5% |
Dizziness |
12.5% |
|
Secondary |
Pneumonia |
24.3% |
Drug Use For Unknown Indication |
17.0% |
Product Used For Unknown Indication |
6.3% |
Electrolyte Substitution Therapy |
5.8% |
Prophylaxis |
5.8% |
Constipation |
3.9% |
Cystitis |
3.9% |
Restlessness |
3.9% |
Thrombosis Prophylaxis |
3.9% |
Bronchitis |
3.4% |
Evidence Based Treatment |
2.9% |
Pyrexia |
2.4% |
Sepsis |
2.4% |
Status Epilepticus |
2.4% |
Acute Coronary Syndrome |
1.9% |
Bronchial Obstruction |
1.9% |
Colitis |
1.9% |
Diarrhoea |
1.9% |
Gastrointestinal Infection |
1.9% |
Hypokalaemia |
1.9% |
|
Staphylococcal Sepsis |
14.7% |
Stevens-johnson Syndrome |
11.8% |
Renal Failure |
8.8% |
Anaphylactic Reaction |
5.9% |
Dry Eye |
5.9% |
Hypotension |
5.9% |
Renal Failure Acute |
5.9% |
White Blood Cell Count Increased |
5.9% |
Aspartate Aminotransferase Increased |
2.9% |
Basedow's Disease |
2.9% |
Deafness |
2.9% |
Developmental Delay |
2.9% |
Human Herpesvirus 6 Infection |
2.9% |
Hypokalaemia |
2.9% |
Myocardial Infarction |
2.9% |
Oedema Peripheral |
2.9% |
Peritoneal Effusion |
2.9% |
Rash Pustular |
2.9% |
Respiratory Gas Exchange Disorder |
2.9% |
Transient Ischaemic Attack |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
33.8% |
Drug Use For Unknown Indication |
24.9% |
Sarcoma Metastatic |
5.6% |
Aortic Valve Replacement |
3.5% |
Chemotherapy |
3.3% |
Coronary Artery Bypass |
2.8% |
Nuclear Magnetic Resonance Imaging |
2.8% |
Pain |
2.4% |
Pyrexia |
2.2% |
Diffuse Large B-cell Lymphoma |
2.1% |
Nuclear Magnetic Resonance Imaging Brain |
2.0% |
Crohn's Disease |
1.9% |
Hiv Infection |
1.9% |
Pseudomonas Infection |
1.7% |
Hypertension |
1.6% |
Sepsis |
1.6% |
Colorectal Cancer |
1.5% |
Mitral Valve Replacement |
1.5% |
Pneumonia |
1.5% |
Depression |
1.4% |
|
Renal Failure |
16.8% |
Pain |
9.3% |
Injury |
8.4% |
Stress |
6.5% |
Fear |
5.6% |
Pyrexia |
5.6% |
Thrombocytopenia |
4.7% |
Unevaluable Event |
4.7% |
Depression |
3.7% |
Febrile Neutropenia |
3.7% |
Haematoma |
3.7% |
Pneumonia |
3.7% |
Pulmonary Embolism |
3.7% |
Anhedonia |
2.8% |
Anxiety |
2.8% |
Candida Test Positive |
2.8% |
Neutropenia |
2.8% |
Off Label Use |
2.8% |
Rash |
2.8% |
Renal Injury |
2.8% |
|